Neil Bhola, Ph.D.
Affiliations: | 2009 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Pharmacology, Molecular BiologyGoogle:
"Neil Bhola"Parents
Sign in to add mentor| Jennifer R. Grandis | grad student | 2009 | University of Pittsburgh | |
| (Investigation of the mechanisms and therapeutic implications of crosstalk between G-protein-coupled receptors and the epidermal growth factor receptor in HNSCC.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Brand TM, Hartmann S, Bhola NE, et al. (2022) Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer. Cancer Research. 82: 3187 |
| Brand TM, Hartmann S, Bhola NE, et al. (2022) Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer. Cancer Research. 82: 3188 |
| Swaney DL, Ramms DJ, Wang Z, et al. (2021) A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity. Science (New York, N.Y.). 374: eabf2911 |
| Bouhaddou M, Lee RH, Li H, et al. (2021) Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer. Jci Insight |
| Bhola NE, Njatcha C, Hu L, et al. (2021) PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance. Head & Neck |
| Brand TM, Hartmann S, Bhola NE, et al. (2021) Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 27: 4129 |
| O'Keefe RA, Bhola NE, Lee DS, et al. (2020) Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance. Plos One. 15: e0227261 |
| Bhola N, Givmanesh A, Wagle M, et al. (2020) Abstract 631: Mat2A Inhibitors decrease growth, increase senescence and p53 stability in MTAP-deleted cancer cells Cancer Research. 80: 631-631 |
| Leonard BC, Lee ED, Bhola NE, et al. (2019) ATR inhibition sensitizes HPV and HPV head and neck squamous cell carcinoma to cisplatin. Oral Oncology. 95: 35-42 |
| Chakrabarty A, Surendran S, Bhola NE, et al. (2019) The H1047R PIK3CA oncogene induces a senescence-like state, pleiotropy and acute HSP90 dependency in HER2+ mammary epithelial cells. Carcinogenesis |